Depression is linked to dry eye disease symptoms in elderly patients

Article

A paper published in Investigative Ophthalmology and Visual Science has revealed an association between dry eye disease (DED) and depression in patients with a normal or slightly reduced tear production.

A paper published in Investigative Ophthalmology and Visual Science has revealed an association between dry eye disease (DED) and depression in patients with a normal or slightly reduced tear production.

The investigation led by Dr Joon Young Hyon, Department of Ophthalmology, Seoul National University Bundang Hospital, Korea, examined 657 Korean patients aged 65 years and over. A six-item Dry Eye Questionnaire was used to assess DED symptoms. The Schirmer test, fluorescein stain score and tear film break-up time (BUT) was used to evaluate DED signs. The Korean equivalent of the Short Geriatric Depression Scale (SGDS-K) was used to identify depression.

Binary logistic linear analysis highlighted the female sex, living in an urban area and a Schirmer score of less than 5 mm as factors contributing towards the risk of developing DED.

Depression was not affected by DED patients with a Schirmer score of less than 5 mm, but was affected by a Schirmer score of more than 5 mm. SGDS-K score was associated with several positive answers in the Dry Eye Questionnaire.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.